Teaching Diabetes Management Using Two Different Methods (Teaching)
30 avril 2026 mis à jour par: Amasya University
The Effects of Teaching Diabetes Management to Nursing Students Using Two Different Methods on Knowledge Level, Critical Thinking, and Self-Efficacy
It is essential to evaluate teaching methods and include comprehensive teaching components for optimal educational outcomes.
Accordingly, this study will evaluate the effect of teaching diabetes management to nursing students using two different methods.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
Introduction and Aim: To provide effective diabetes education for nursing students, it is essential to evaluate teaching methods and include comprehensive teaching components for optimal educational outcomes. Accordingly, this study will evaluate the effect of teaching diabetes management to nursing students using two different methods.
Methods: The research will be conducted using a quasi-experimental research design with a pre-test/post-test control group. The sample will consist of students enrolled in the Internal Medicine Nursing course at a university nursing department. Data will be collected in two time periods: after theoretical information on diabetes and treatment/care practices is provided, and after jigsaw and case-based learning applications are completed. Students will be divided into three groups: jigsaw learning group, case-based learning group, and control group. Data will be collected using a Personal Information Form, Diabetes Knowledge Test, Critical Thinking Tendency Scale, and Self-Efficacy Scale.
Type d'étude
Interventionnel
Inscription (Réel)
88
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
-
Amasya, Turquie (Türkiye)
- AmasyaU
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Oui
La description
Inclusion Criteria:
- Students enrolled in the Internal Medicine Nursing course during the 2023-2024 academic year,
- Students who attended the "diabetes management" theoretical course in Internal Medicine Nursing,
- Students who agreed to participate in the study.
Exclusion Criteria:
- Students who did not participate in the theoretical and jigsaw/case-based learning application phases of the study,
- Students who did not give their consent to participate in the study.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Non randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: jigsaw
Students in the jigsaw group will be divided into 5 groups of six.
Then, the topic content will be divided into five outlines (diabetes classification/symptoms and signs, diabetes treatment (nutrition and exercise), diabetes treatment (insulin and oral antidiabetics), acute and chronic complications of diabetes, patient education in diabetes), and each member of each jigsaw group will be assigned to a specific outline.
Students will be asked to study all the material by looking more closely at the given topic.
Then, all students assigned to the same outline in the 5 jigsaw groups will be gathered in a group called the "expert group."
In this expert group, each student will be asked to share and discuss the information they have gained regarding the specific outline with the other students.
|
Students in the jigsaw group will be divided into 5 groups of six.
Then, the topic content will be divided into five outlines (diabetes classification/symptoms and signs, diabetes treatment (nutrition and exercise), diabetes treatment (insulin and oral antidiabetics), acute and chronic complications of diabetes, patient education in diabetes), and each member of each jigsaw group will be assigned to a specific outline.
Students will be asked to study all the material by looking more closely at the given topic.
Then, all students assigned to the same outline in the 5 jigsaw groups will be gathered in a group called the "expert group."
In this expert group, each student will be asked to share and discuss the information they have gained regarding the specific outline with the other students.
|
|
Expérimental: case based
The researcher will provide the students with 5 examples, and five case studies will be conducted with the students in the case-based learning group (cases will include information such as the patient's detailed history, medical diagnosis, a brief summary of the disease, and the medications the patient is using).
The case studies used will contain the basic details of diabetes.
Necessary background information will be provided, and discussion questions will be determined.
|
The researcher will provide the students with 5 examples, and five case studies will be conducted with the students in the case-based learning group (cases will include information such as the patient's detailed history, medical diagnosis, a brief summary of the disease, and the medications the patient is using).
The case studies used will contain the basic details of diabetes.
Necessary background information will be provided, and discussion questions will be determined.
|
|
Aucune intervention: control
Control group: Students in the control group will not be given the simulation exercise; they will only fill out data collection forms during two designated time periods.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Diabetes Knowledge Test
Délai: 4 week
|
The knowledge test will consist of 20 questions on the physiology, signs, and treatment of septic shock.
The questions in the knowledge test will be sent to 5 experts for review, and content validity will be established.
|
4 week
|
|
Critical Thinking Tendency Scale
Délai: 4 week
|
The "Critical Thinking Tendency Scale" was developed in 2012 by Karalı and Battal to measure critical thinking tendencies.
The CTTS is a five-point Likert-type scale consisting of 21 items.
The scale has two sub-dimensions: "Skills Dimension" and "Values Dimension".
The Cronbach's alpha internal consistency reliability coefficient of the scale was found to be 0.91 (Karalı and Battal, 2012).
The highest possible score on the "Skills" subscale of the "Critical Thinking Tendency Scale" is 60, and the lowest is 12.
The highest possible score on the "Values" subscale is 45, and the lowest is 9.
The Cronbach's alpha internal consistency reliability coefficient of the scale was found to be 0.91.
|
4 week
|
|
Self-Efficacy Scale
Délai: 4 week
|
The scale is unidimensional and consists of 10 positive items, therefore it does not contain reverse-coded items.
Each item is given a score between 1 and 4, in equal intervals.
A higher score indicates higher self-efficacy.
The Cronbach's alpha internal consistency reliability coefficient of the scale adapted into Turkish and whose validity and reliability analyses were performed by Yurtçiçek Eren and Başgöl was found to be 0.81.
|
4 week
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
15 octobre 2025
Achèvement primaire (Réel)
15 décembre 2025
Achèvement de l'étude (Réel)
16 janvier 2026
Dates d'inscription aux études
Première soumission
24 avril 2026
Première soumission répondant aux critères de contrôle qualité
30 avril 2026
Première publication (Réel)
4 mai 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
4 mai 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
30 avril 2026
Dernière vérification
1 avril 2026
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- AU-689
- NU689 (Autre identifiant: Amasya U)
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .